Sinopharm Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
80
- Portfolio
-
45
- Exits
-
26
Sinopharm Capital General Information
Company Description
Founded in 2012, Sinopharm Capital is a venture capital arm of Sinopharm Group based in Shanghai, China. The firm prefers to invest in the healthcare, life science, and biotechnology sectors.
Business Details
Website
www.sinopharmcapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 16th Floor, Shen Building
- Number 266 Hankou Road, Huangpu District
- Shanghai, 200001
- China
Sinopharm Capital Investments (80)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ray Everest | 23-Aug-2023 | Early Stage VC | Discovery Tools (Healthcare) | Generating Revenue | ||
| Longwell (Medical Robotics) | 01-Sep-2022 | Laboratory Services (Healthcare) | Generating Revenue | |||
| AstraBio (China) | 29-Jun-2022 | Diagnostic Equipment | Generating Revenue | |||
| OriCell Therapeutics | 09-Jun-2022 | Drug Discovery | Generating Revenue | |||
| Artivila Therapeutics | 31-Mar-2022 | Drug Discovery | Generating Revenue | |||
| MetaNovas Biotech | 31-Mar-2022 | Biotechnology | Generating Revenue | |||
| CytoNiche | 03-Mar-2022 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Singlomics | 14-Feb-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Sumgen | 29-Dec-2021 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Longwell (Medical Robotics) | 24-Nov-2021 | Early Stage VC | Laboratory Services (Healthcare) | Generating Revenue |
Sinopharm Capital Exits (26)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Kira Pharma | 16-Jul-2026 | Merger/Acquisition | |
| Ray Everest | 23-Jun-2026 | ||
| Virogin Biotech | 01-Jun-2026 | ||
| AND Technology | 10-Feb-2026 | ||
| Genfleet | 19-Sep-2025 | ||
| Kanglu Bio | 05-Aug-2025 | ||
| Suzhou Sepax Technologies | 10-Jan-2025 | ||
| YesSkin | 31-Oct-2024 | ||
| ECCOGENE | 24-Jan-2024 | Secondary Transaction - Private | |
| ECCOGENE | 08-Jan-2024 | Secondary Transaction - Private |
Sinopharm Capital Investments by Industry, Year, and Region
Sinopharm Capital Co-Investors (35)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Huagai Capital | 2 |
|
|
||
| Detong Capital |
|
|
|||
| Legend Capital |
|
|
|||
| Leica Microsystems |
|
|
|||
| Qiming Venture Partners |
|
|
Sinopharm Capital FAQs
-
What is Sinopharm Capital?
Founded in 2012, Sinopharm Capital is a venture capital arm of Sinopharm Group based in Shanghai, China.
-
When was Sinopharm Capital founded?
Sinopharm Capital was founded in 2012.
-
Where is Sinopharm Capital headquartered?
Sinopharm Capital is headquartered in Shanghai, China.
-
How many investments has Sinopharm Capital made?
Sinopharm Capital has made 80 investments.
-
What has Sinopharm Capital invested in?
Sinopharm Capital has made numerous investments in companies like Ray Everest, Longwell (Medical Robotics), and AstraBio (China) within the Discovery Tools (Healthcare), Laboratory Services (Healthcare), and Diagnostic Equipment industries.
-
What has Sinopharm Capital invested in recently?
Sinopharm Capital's latest investment was on 23-Aug-2023 in Ray Everest, a company within the Discovery Tools (Healthcare) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process